Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA vaccination against oncoantigens: A promise.
Iezzi M, Quaglino E, Amici A, Lollini PL, Forni G, Cavallo F. Iezzi M, et al. Among authors: cavallo f. Oncoimmunology. 2012 May 1;1(3):316-325. doi: 10.4161/onci.19127. Oncoimmunology. 2012. PMID: 22737607 Free PMC article.
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.
Bolli E, O'Rourke JP, Conti L, Lanzardo S, Rolih V, Christen JM, Barutello G, Forni M, Pericle F, Cavallo F. Bolli E, et al. Among authors: cavallo f. Oncoimmunology. 2017 Dec 6;7(3):e1408746. doi: 10.1080/2162402X.2017.1408746. eCollection 2018. Oncoimmunology. 2017. PMID: 29399412 Free PMC article.
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.
Donofrio G, Tebaldi G, Lanzardo S, Ruiu R, Bolli E, Ballatore A, Rolih V, Macchi F, Conti L, Cavallo F. Donofrio G, et al. Among authors: cavallo f. Oncoimmunology. 2018 Sep 6;7(12):e1494108. doi: 10.1080/2162402X.2018.1494108. eCollection 2018. Oncoimmunology. 2018. PMID: 30524888 Free PMC article.
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Di Lorenzo A, Bolli E, Ruiu R, Ferrauto G, Di Gregorio E, Avalle L, Savino A, Poggio P, Merighi IF, Riccardo F, Brancaccio M, Quaglino E, Cavallo F, Conti L. Di Lorenzo A, et al. Among authors: cavallo f. Oncoimmunology. 2022 Jun 15;11(1):2086752. doi: 10.1080/2162402X.2022.2086752. eCollection 2022. Oncoimmunology. 2022. PMID: 35756841 Free PMC article.
Xenogene vaccination in the therapy of cancer.
Cavallo F, Aurisicchio L, Mancini R, Ciliberto G. Cavallo F, et al. Expert Opin Biol Ther. 2014 Oct;14(10):1427-42. doi: 10.1517/14712598.2014.927433. Epub 2014 Jul 15. Expert Opin Biol Ther. 2014. PMID: 25023219 Free article. Review.
Antitumor immunization of mothers delays tumor development in cancer-prone offspring.
Barutello G, Curcio C, Spadaro M, Arigoni M, Trovato R, Bolli E, Zheng Y, Ria F, Quaglino E, Iezzi M, Riccardo F, Holmgren L, Forni G, Cavallo F. Barutello G, et al. Among authors: cavallo f. Oncoimmunology. 2015 Feb 3;4(5):e1005500. doi: 10.1080/2162402X.2015.1005500. eCollection 2015 May. Oncoimmunology. 2015. PMID: 26155401 Free PMC article.
998 results